5 Hiv Aids in Pregnancy
5 Hiv Aids in Pregnancy
5 Hiv Aids in Pregnancy
PREGNANCY
By Mengistu Lopiso , (MD ,GP)
06/06/2022 1
• Learning objectives:
Describe the four prongs of PMTCT
List components of PMTCT
Describe option B+
List the benefits of Option B+
06/06/2022 2
Gynecological Issues
• Conditions causing inflammation or infection increase the
likelihood a woman will acquire or transmit HIV.
• Bacteral vaginosis
• Cervicitis
• Herpes ulcers
• Genital warts
• Condyloma.
• Recurrent candidiasis
• Prevalent in 25 – 30% of women with HIV
• Risk increases 20 fold with CD4 <100.
06/06/2022 3
HIV and Pregnancy
• Pregnancy does not accelerate the progression of HIV disease to AIDS.
• Cd4 count may decrease up to 50 cell/mm3 but return to its pre pregnancy
state.
• Patients with AIDS are more likely to suffer from pregnancy related
complications.
06/06/2022 4
06/06/2022 5
WHO’s 4-prong approach to PMTCT
1. Primary prevention of HIV infection
2. Prevention of unintended pregnancy
3. Prevention of mother to child transmission
4. Linkage to care & support
06/06/2022 6
PRONG 1: Preventing HIV infection among
women of reproductive age
• 50% reduction in the number of women 15–49 years old acquiring HIV
infection by 2015.
• Primary prevention during pregnancy.
• Education about safer sex with use of condoms.
• Early treatment of STIs.
• Safer sex during pregnancy and lactation.
• PICT
• Ensuring comprehensive, correct knowledge about how to prevent HIV
transmission.
06/06/2022 7
Prong 2: Preventing unintended pregnancies
among women living with HIV
• By providing family planning services
• Decreasing the level of unmet need
06/06/2022 8
Prong 3: PMTCT
06/06/2022 9
Effect of HIV on pregnancy
• Spontaneous abortion
• IUGR
• Preterm delivery
• Low birth weight
• Still birth
• Perinatal mortality
• New born mortality
• Decreased fertility
06/06/2022 10
Timing of mother to child transmission
During pregnancy
(5-10%)
During breastfeeding
(5-10%)
06/06/2022 11
Factors that increase MTCT
Viral
Viral load (the higher the viral load, the greater the risk of HIV transmission)
Viral genotype and phenotype
Viral resistance
Maternal
Maternal immunological status
Maternal nutritional status
New infection with HIV during pregnancy
Maternal clinical status (including co-infection with an STI)
Behavioral factors
Antiretroviral treatment
06/06/2022 12
Obstetrical
Prolonged rupture of membrane (longer than 4 hours)
Mode of delivery
Intrapartum hemorrhage
Obstetrical procedures
Invasive fetal monitoring
Chorioamnionitis
Fetal
Prematurity
Genetic
Multiple pregnancy
06/06/2022 13
Infant
Breastfeeding
Gastrointestinal tract factors
Immature immune system
06/06/2022 14
Option of ARV
06/06/2022 15
•Option B+
06/06/2022 16
What is option B+
“Test and treat” strategy in which triple ARVs are started as soon as
HIV is detected in a pregnant woman irrespective of CD4 count and
gestational age
• Treatment (ART) intended to be given for life
• Specific ART regimen that requires just once a day dosing (either
with one or two tablets), which will result in convenience for the
patient and good drug adherence
06/06/2022 17
What are the Benefits of Option B+
• Requires just one/two pills taken once daily
• No need for CD4 test to initiate ART
• Makes breast feeding safer
• Avoids the need for extended infant ARV prophylaxis (Option A)
• Mothers start treatment early, so quality of life and survival are better
• Maintains continuity of care: ANC to post-weaning so improves infant
testing as well as post-partum uptake of FP services.
• Minimize HIV transmission among discordant partnership
• Ongoing treatment of mother will protect future pregnancies from moment
of conception.
06/06/2022 18
06/06/2022 19
06/06/2022 20
EFV IN PREGNACY
• Better long term viral suppression
• Less adverse effect
• Less risk of resistance
06/06/2022 21
Initiating ART at ANC for HIV positive pregnant/ lactating women
06/06/2022 22
Ethiopia’s 1st Line ART Regimen for HIV
positive pregnant & lactating women
1. Women diagnosed at ANC, labor, or post-partum should started
TDF/3TC/EFV as soon as diagnosed.
2. Women started on TDF/3TC/EFV prior to pregnancy can transfer their ART
care to the PMTCT service provider integrated into MNCH care.
3. Women who get pregnant while on an ART regimen other than
TDF/3TC/EFV should continue the same regimen
4. If woman on a non-TDF/3TC/EFV regimen wishes to have ART managed at
PMTCT site, her ART Clinic provider must determine it is safe to switch
regimens to TDF/3TC/EFV and agree to do so
06/06/2022 23
Detailed option B+: Recommendations
1.During pregnancy:
06/06/2022 24
2. During labor and Delivery:
06/06/2022 25
3. Lactating or post partum.
06/06/2022 26